Danish pharmaceutical company DanCann Pharma’s first factory to develop and manufacture cannabinoids for a wide range of diseases has now started operations. CEO and founder Jeppe Krog Rasmussen tells us more about this milestone and the plans ahead. We also learn why he further strengthened his ownership in the company and why an option program was launched for senior management.
Read the full interview with Jeppe Krog Rasmussen at biostock.se:
This is a press release from BioStock – combining innovation and capital. https://www.biostock.se/
(c) 2021 Cision. All rights reserved., Source Press Releases – English